IRIS
OLIVIERI, Attilio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.603
EU - Europa 5.780
AS - Asia 1.472
Continente sconosciuto - Info sul continente non disponibili 55
SA - Sud America 10
OC - Oceania 4
AF - Africa 1
Totale 16.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.574
UA - Ucraina 1.451
IE - Irlanda 937
SE - Svezia 794
TR - Turchia 706
IT - Italia 693
DE - Germania 683
DK - Danimarca 592
FI - Finlandia 331
SG - Singapore 318
KR - Corea 310
GB - Regno Unito 174
FR - Francia 66
CN - Cina 62
EU - Europa 54
IN - India 50
CA - Canada 26
BE - Belgio 22
JP - Giappone 11
NL - Olanda 10
RU - Federazione Russa 7
BR - Brasile 6
CH - Svizzera 4
ES - Italia 4
GR - Grecia 4
HK - Hong Kong 4
IR - Iran 4
PL - Polonia 4
AU - Australia 3
BZ - Belize 3
IL - Israele 3
CO - Colombia 2
PE - Perù 2
TH - Thailandia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
CZ - Repubblica Ceca 1
MD - Moldavia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 16.925
Salva come PNG Salva come JPEG
Città #
Jacksonville 1.572
Chandler 1.023
Fairfield 945
Dublin 932
Ashburn 540
Wilmington 518
Boardman 419
Houston 382
Woodbridge 363
Lawrence 358
Princeton 358
Seattle 343
Des Moines 324
San Mateo 321
Cambridge 257
Ann Arbor 252
New York 243
San Diego 139
Centro 104
Turin 71
Redmond 70
Milan 57
Beijing 56
London 47
Pune 37
Washington 37
Los Angeles 36
Venice 30
Pianella 27
Porto 27
Helsinki 26
Marche 24
Izmir 23
Norwalk 20
Brussels 18
Prescot 17
Ancona 16
Kilburn 13
Frankfurt am Main 11
Ottawa 11
Rome 10
Civitanova Marche 9
Falls Church 9
Hanover 9
Chiswick 8
Wandsworth 8
Montréal 7
New Bedfont 7
Palermo 7
Southwark 7
Dallas 6
Hounslow 6
Jesi 6
Tolentino 6
Andover 5
Bologna 5
Catania 5
Leawood 5
Licata 5
Menlo Park 5
Modena 5
Mumbai 5
Bristol 4
Fayetteville 4
Kagoya 4
Lowell 4
Maglie 4
Osimo 4
Pesaro 4
Toronto 4
Acton 3
Auburn Hills 3
Chicago 3
Huskvarna 3
Izhevsk 3
Pistoia 3
Redwood City 3
San Benedetto del Tronto 3
Tokyo 3
Vitulano 3
Altamura 2
Athens 2
Bangkok 2
Bern 2
Brighton 2
Capannori 2
Caserta 2
Claremont 2
Cremona 2
Deiva Marina 2
Falconara Marittima 2
Fano 2
Florence 2
Genova 2
Giavera del Montello 2
Gwangju 2
Hadera 2
Hong Kong 2
Iesi 2
Lima 2
Totale 10.314
Salva come PNG Salva come JPEG
Nome #
Serum Inflamma-miR Signature: A Biomarker of Myelodysplastic Syndrome? 145
Conditioning regimen with beam plus amifostine for outpatient autologous stem cell tansplantation: feasibility and outcome in 97 lymphoma patients. 114
Low-dose Gemtuzumab-Ozogamicin as post-consolidation therapy in elderly patients with acute myeloid leukaemia: a pilot study. 103
Glial-like differentiation potential of human mature adipocytes 103
A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study. 102
A Comparison of the Conditioning Regimens BEAM and FEAM for Autologous Hematopoietic Stem Cell Transplantation in Lymphoma: An Observational Study on 1038 Patients From Fondazione Italiana Linfomi 101
A novel method to evaluate prethawing viability of cryopreserved CD34+ hematopoietic stem cells for autologous transplantation. 96
Common and rare side-effects of low-dose thalidomide in multiple myeloma: focus on the dose-minimizing peripheral neuropathy 95
Azacitidine Treatment in High Risk Myelodysplastic Patients in Complete Haematological Remission Reverts Mesenchymal Stem Cells to a Normal Phenotype 95
Stimulatory autoantibodies to PDGF receptor in patients with extensive chronic graft-versus-host disease 94
A predictive model of varicella-Zoster virus infection after autologous peripheral blood progenitor cell transplantation 93
Predicting failure of hematopoietic stem cell mobilization before it starts: The predicted poor mobilizer (pPM) score 93
Gene expression profile of cytokines in patients with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with reduced conditioning. 91
The exosomal surface phenotype and inflamma-miR cargo correlate with MDS diagnosis 88
Thalidomide, dexamethasone, and pegylated liposomal doxorubicin (ThaDD) for patients older than 65 years with newly diagnosed multiple myeloma. 88
Plasticity of human dedifferentiated adipocytes toward endothelial cells 86
Efficacy and feasibility of high-dose cytarabine plus idarubicin and amifostine as induction schedule: a prospective observational study of 100 AML elderly patients 85
Feasibility and Outcome of a Phase II Study of Intensive Induction Chemotherapy in 91 Elderly Patients with AML Evaluated Using a Simplified Multidimensional Geriatric Assessment 84
Bendamustine, Bortezomib and Dexamethasone (BVD): A Combination With a Substantial Activity and a Manageable Toxicity In Patients With Relapsed-Refractory Multiple Myeloma (MM) 83
Direct demonstration of cytokeratin filaments by electron microscopy in K562 cell lines in liquid culture 81
The Exaggerated Collagen Expression in Gvhd-Fibroblasts Is Effectively Inhibited By Therapeutic Concentration of Nilotinib 81
Reversal of poor graft function with iron-chelating therapy after allogeneic transplantation for severe aplastic anemia 80
Immunomodulatory Effects of Tyrosine Kinase Inhibitor In Vitro and In Vivo Study 79
PBSC mobilization, collection and positive selection in patients with chronic lymphocytic leukemia. 79
Hematologic reconstitution after PBPC autotransplantation:comparison between programmed-rate freezing and uncontrolled freezing at –80° 78
In vitro comparison of different TKI activity in T-Cell populations: selective sparing of Treg by Nilotinib. 78
Molecular and functional characterization of human bone marrow adipocytes 78
Mobilization-Driven Postconsolidation Therapy in Elderly Patients with Acute Myeloid Leukemia: Feasibility and Efficacy of Autologous Stem Cell Transplantation versus Low-Dose Gemtuzumab Ozogamicin 77
Application of infrared thermography to determine the correlation between skin temperature and onset of graft versus host disease in patients after bone marrow transplantation: A preliminary study 76
Tailored Therapy in an Unselected Population of 91 Elderly Patients with DLBCL Prospectively Evaluated Using a Simplified CGA. 75
A Combination of Lenalidomide and Rituximab (ReRi) As Salvage Therapy in Elderly Patients Affected By Diffuse Large B Cells (DLBCL) Lymphoma Relapsed and Refractory 75
Amifostine can reduce mucosal damage after high-dose melphalan conditioning for peripheral blood progenitor cell autotransplant: a retrospective study 74
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study 74
Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: A GITMO survey on 809 patients autografted in first complete remission 74
Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: A survey from the ALWP of the EBMT 74
A new method to assess the viability of collected CD34+ cells before reinfusion: a prospective study in 50 autotransplanted patients. 72
Infections by carbapenem-resistant Klebsiella pneumoniae in SCT recipients: A nationwide retrospective survey from Italy 72
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 71
Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD 71
Interaction between human mature adipocytes and lymphocytes induces T-cell proliferation 71
The Time Has Come for Targeted Therapies for AML: Lights and Shadows 71
Severe COVID-19 in a patient with chronic graft-versus-host disease after hematopoietic stem cell transplant successfully treated with ruxolitinib 71
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease 71
DHAP in combination with rituximab vs DHAP alone as salvage treatment for patients with relapsed or refractory diffuse large B-cell lymphoma: a matched-pair analysis. 71
Efficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study 71
Reduced-intensity conditioning followed by allografting of hematopoietic cells can produce clinical and molecular remissions in patients with poor-risk hematologic malignancies 70
Prognostic role of immunohistochemical analysis of 5 mc in myelodysplastic syndromes. 70
Overexpression of CDKN2B (p15INK4B) and altered global DNA methylation status in mesenchymal stem cells of high-risk myelodysplastic syndromes 70
Safety and Efficacy of Thiotepa-Based Conditioning Therapy for Allogeneic Transplantation in Acute Myeloid Leukemia - a Survey from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation 70
DNA demethylating therapy reverts mesenchymal stromal cells derived from high risk myelodysplastic patients to a normal phenotype 70
Modern management of anthracycline-induced cardiotoxicity in lymphoma patients: Low occurrence of cardiotoxicity with comprehensive assessment and tailored substitution by nonpegylated liposomal doxorubicin 70
LATE EFFECTS IN Hodgkin's POPULATION Treated BETWEEN 1980-2005 IN A SINGLE INSTITUTION 69
'Real-life' report on the management of chronic GvHD in the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 69
Neurologic Complications IIN 169 Consecutive Allogeneic Stem Cell Transplants: Etiology, Clinical Syndromes and Outcome 69
Low-dose thalidomide with pegylated liposomal doxorubicin and high-dose dexamethasone for relapsed/refractory multiple myeloma: a prospective, multicenter, phase II stud 68
Gemcitabine alone or combined with cisplatin in relapsed or refractory multiple mieloma 68
A new schedule of CHOP/rituximab plus granulocyte-macrophage colony-stimulating factor is an effective rescue for patients with aggressive lymphoma failing autologous stem cell transplantation. 68
In vivo purging with bortezomib and cyclophosphamide, followed by autologous stem cell transplantation and thalidomide consolidation in elderly patients with multiple myeloma 67
Response: Imatinib in lung cGVHD of mild to moderate severity 67
Preventive Effects of Cardotoxicities By Liposomal Anthracyclines non Pegilated in 95 Perspective Patients Affected By Lymphoma and Monitored By Biomarkers and Ecocardiography 67
Growth factor administration following autologous peripheral blood progenitor cell transplantation. 67
A Prospective Study on the Feasibility of Related and Unrelated Donor Search and Hematopoietic Cell Transplantation for Adults with Acute Leukemia at 31 European Transplant Centers. 66
A policy for the disposal of autologous hematopoietic progenitor cells: report from an Italian consensus panel 66
Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma 66
Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma 66
Tirosin kinase inhibitors in chronic graft versus host disease: from bench to bedside. 65
Paroxysmal atrial fibrillation after high-dose melphalan in five patients autotransplanted with blood progenitor cells. 65
Radioimmunotherapy (Y-90-Zevalin (R)) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study 65
Application of growth factors in hematopoietic stem cell transplant [Impiego dei fattori di crescita nel trapianto di cellule staminali emopoietiche] 65
T Repleted Haploidentical Mismatch Allogeneic Versus Autologous Hematopoietic Stem Cell Transplantation In Adult Patients With Acute Leukemia In Complete Remission (CR): A pair-Matched Analysis From The Acute Leukemia Working Party Of EBMT 65
Addition of rituximab to involved-field radiation therapy prolongs progression-free survival in stage I-II follicular lymphoma: Results of a multicenter study 65
Gemtuzumab-Ozogamicin as Post-Consolidation Therapy In Elderly Patients with Acute Myeloid Leukemia: a Pilot Study 65
Bone marrow adipocytes support haematopoietic stem cell survival 65
Infectious complications after autologous peripheral blood progenitor cell transplantation followed by G-CSF. 64
Consensus recommendations for improvement of unmet clinical needs-the example of chronic graft-versus-host disease: A systematic review and meta-analysis 64
Performance of high-frequency ultrasound in the evaluation of skin involvement in cutaneous chronic graft-versus-host disease: A preliminary report 64
Mobilization policy in multiple myeloma: Minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean 63
A new intensive induction schedule, including high-dose Idarubicin, high-dose Aracytin and Amifostine, in older AML patients: feasibility and long-term results in 42 patients. 62
[Hodgkin's lymphoma and secondary leukemias]. 62
History and scientific production of clinica medica and clinica ematologica in ancona 61
Scleroderma-like fibrosis in chronic graft-vs-host disease is sustained by anti-PDGF receptors antibodies 60
Engraftment capacity of mesenchymal cells following hematopoietic stem cell transplantation in patients receiving reduced-intensity conditioning regimen. 60
Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinicobiological features in consecutive patients analyzed on tissue microarrays. 60
Lenalidomide and low dose dexamethasone for newly diagnosed primary plasma cell leukemia 60
A multicentre, double-blind, randomised trial comparing ondansetron versus ondansetron plus dexamethasone in the prophylaxis of cisplatin-induced delayed emesis 60
LA POSITIVITÀ DEL WT1 POST-INDUZIONE È UN IMPORTANTE FATTORE PROGNOSTICO PREDITTIVO DI RECIDIVA PRECOCE IN UNA CASISTICA DI 80 PAZIENTI AFFETTI DA LEUCEMIA ACUTA MIELOIDE 60
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation 60
Central pontine myelinolysis after hematopoietic stem cell transplantation: survey in 169 consecutive transplanted patients and review of literature 60
Cytokine expression profile of selected cell populations from patients with chronic graft-versus-host disease after allogeneic bone marrow transplantation wih reduced conditioning. 59
BEEAM (BENDAMUSTINE, ETOPOSIDE, ARA-C, MELPHALAN) PRIOR TO AUTOLOGOUS STEM CELL TRANSPLANT IS SAFE AND EFFECTIVE IN AGGRESSIVE B-CELL NON HODGKIN LYMPHOMA: A PHASE II MULTICENTER STUDY 59
VERY LOW TOXICITY AND GOOD QUALITY OF LIFE IN 48 ELDERLY PATIENTS AUTOTRANSPLANTED FOR HEMATOLOGICAL MALIGNANCIES: A SINGLE CENTER EXPERIENCE 58
Telomere length, c-myc and mad-1 expression could represent prognosis markers of myelodysplastic syndrome 58
Incidence and Outcome of Invasive Fungal Diseases after Allogeneic Stem Cell Transplantation: A Prospective Study of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) 58
DHAP regimen plus G-CSF as salvage therapy and priming for blood progenitor cell collection in patients with poor prognosis lymphoma. 57
Best practice recommendations in: (1) Peripheral blood stem cell mobilization and collection and (2) acute and chronic GvHD treatment using extracorporeal photopheresis. A joint effort from SIdEM (Società Italiana di Emaferesi e Manipolazione Cellulare) and GITMO (Gruppo Italiano Trapianto di Midollo Osseo) 57
OVEREXPRESSION OF CDKN2B IS ASSOCIATED WITH REDUCED PROLIFERATIVE POTENTIAL IN MESENCHYMAL STEM CELL FROM HIGH-RISK MYELODYSPLASTIC SYNDROME 57
Kinetics of the use of cryopreserved autologous stem cell grafts: a GITMO-SIDEM survey 56
Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma 56
Results of a randomized trial comparing high-dose chemotherapy plus Auto-SCT and R-FC in CLL at diagnosis 56
Combined administration of alpha-erythropoietin and filgrastim can improve the outcome and cost balance of autologous stem cell transplantation in patients with lymphoproliferative disorders. 55
Totale 7.273
Salva come PNG Salva come JPEG
Categoria #
all - tutte 97.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.602
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201939 0 0 0 0 0 0 0 0 0 0 9 30
2019/20201.834 23 7 335 10 329 3 336 11 322 13 54 391
2020/20213.868 196 433 522 84 481 267 376 193 445 256 436 179
2021/20222.695 123 692 35 184 18 91 172 220 137 236 206 581
2022/20233.672 442 395 366 231 213 498 9 162 1.019 16 240 81
2023/20242.141 453 64 136 431 439 402 70 58 16 66 6 0
Totale 17.383